Consistent with our findings, astaxanthin, a dietary carotenoid that is a structurally similar to βCAR, showed a substantial decrease in cerebral infarction and caspase-3 activity with an increase in post-stroke locomotor activity after MCAO in rats [55]. Here, CASP3 is linked to cerebral infarction.